Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis

Naobumi Hosogane, Kota Watanabe, Takashi Tsuji, Takeshi Miyamoto, Ken Ishii, Yasuo Niki, Masaya Nakamura, Yoshiaki Toyama, Kazuhiro Chiba, Morio Matsumoto

研究成果: Article

6 引用 (Scopus)

抄録

Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

元の言語English
ページ(範囲)1249-1253
ページ数5
ジャーナルJournal of Orthopaedic Research
30
発行部数8
DOI
出版物ステータスPublished - 01-08-2012
外部発表Yes

Fingerprint

Scoliosis
Cartilage
Biomarkers
Serum
Collagen Type II
Cartilage Oligomeric Matrix Protein
Keratan Sulfate
Hyaluronic Acid
Zygapophyseal Joint
Osteoarthritis
Collagen
Extremities
Joints

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine

これを引用

Hosogane, N., Watanabe, K., Tsuji, T., Miyamoto, T., Ishii, K., Niki, Y., ... Matsumoto, M. (2012). Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. Journal of Orthopaedic Research, 30(8), 1249-1253. https://doi.org/10.1002/jor.22067
Hosogane, Naobumi ; Watanabe, Kota ; Tsuji, Takashi ; Miyamoto, Takeshi ; Ishii, Ken ; Niki, Yasuo ; Nakamura, Masaya ; Toyama, Yoshiaki ; Chiba, Kazuhiro ; Matsumoto, Morio. / Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. :: Journal of Orthopaedic Research. 2012 ; 巻 30, 番号 8. pp. 1249-1253.
@article{b36912c9ad894218b9531d31d5944cdc,
title = "Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis",
abstract = "Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.",
author = "Naobumi Hosogane and Kota Watanabe and Takashi Tsuji and Takeshi Miyamoto and Ken Ishii and Yasuo Niki and Masaya Nakamura and Yoshiaki Toyama and Kazuhiro Chiba and Morio Matsumoto",
year = "2012",
month = "8",
day = "1",
doi = "10.1002/jor.22067",
language = "English",
volume = "30",
pages = "1249--1253",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "8",

}

Hosogane, N, Watanabe, K, Tsuji, T, Miyamoto, T, Ishii, K, Niki, Y, Nakamura, M, Toyama, Y, Chiba, K & Matsumoto, M 2012, 'Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis', Journal of Orthopaedic Research, 巻. 30, 番号 8, pp. 1249-1253. https://doi.org/10.1002/jor.22067

Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis. / Hosogane, Naobumi; Watanabe, Kota; Tsuji, Takashi; Miyamoto, Takeshi; Ishii, Ken; Niki, Yasuo; Nakamura, Masaya; Toyama, Yoshiaki; Chiba, Kazuhiro; Matsumoto, Morio.

:: Journal of Orthopaedic Research, 巻 30, 番号 8, 01.08.2012, p. 1249-1253.

研究成果: Article

TY - JOUR

T1 - Serum cartilage metabolites as biomarkers of degenerative lumbar scoliosis

AU - Hosogane, Naobumi

AU - Watanabe, Kota

AU - Tsuji, Takashi

AU - Miyamoto, Takeshi

AU - Ishii, Ken

AU - Niki, Yasuo

AU - Nakamura, Masaya

AU - Toyama, Yoshiaki

AU - Chiba, Kazuhiro

AU - Matsumoto, Morio

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

AB - Several biomarkers have been used to evaluate osteoarthritis of the limb joints. Here we evaluated the use of serum cartilage metabolites as biomarkers for degenerative lumbar scoliosis (DLS). Fifty-two DLS patients with Cobb angle>10° were compared with 19 control patients. Serum levels of hyaluronic acid (HA), keratan sulfate (KS), cartilage oligomeric matrix protein (COMP), collagen type II cleavage (C2C), and procollagen type II C-propeptide (CPII) were measured. Serum levels of KS (DLS 1.20±0.44μg/ml vs. control 0.98±0.33μg/ml), CPII (DLS 1905.1±948.2ng/ml vs. control 1223.6±884.4ng/ml), and C2C (DLS 219.1±59.2ng/ml vs. control 177.7±71.7ng/ml) were significantly higher in DLS. There were no significant differences in the levels of HA or COMP. There was a significant positive correlation between the Cobb angle and CPII in DLS. This is the first study to evaluate the cartilage biomarkers in DLS. The results suggest DLS patients have higher levels of type II collagen synthesis and degradation, indicated by elevated serum CPII and C2C, respectively. As type II collagen is a major component of collagens in the nucleus pulposus and facet joint cartilages, its enhanced turnover may be related to the development and progression of DLS.

UR - http://www.scopus.com/inward/record.url?scp=84862755173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862755173&partnerID=8YFLogxK

U2 - 10.1002/jor.22067

DO - 10.1002/jor.22067

M3 - Article

C2 - 22247038

AN - SCOPUS:84862755173

VL - 30

SP - 1249

EP - 1253

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 8

ER -